top of page

Warning Not To Fall Foul Of R&D Claims With HMRC


ree

UK accountancy firm Azets is seeing a rise in R&D claims but warns against companies trying to use the government-backed tax relief scheme as a ‘backdoor’ way to avoid paying more corporation tax.


Valid R&D claims have the additional benefit of reducing corporation tax liabilities on annual profits of £250,000-plus. Successful claims, which can often amount to tens of thousands of pounds, appear as a credit in the tax part of the profit/loss account and are exempt from corporation tax.


The original 19% corporation tax rate still applies to profits below £50,000, with marginal relief on profits up to the £250,000 threshold. Then the new 25% rate – a 6% rise – kicked in from 1 April this year.


Stephen Harris, a corporate tax expert with UK top 10 accountancy Azets, working from the Durham office, said: “With corporation tax rates having increased to 25% when profits are over £250,000, valid R&D claims have the additional benefit of reducing corporation tax liabilities. Whilst the rate of relief has reduced, the tax relief available is still substantial.”


He added: “Companies thinking of reducing the tax take on annual profits through R&D tax reliefs need to ensure they get professional advice to avoid falling foul of HMRC, which is rightly targeting fraudulent claims.”


Azets warned earlier this month [September] that nearly half of submissions made by agents across the UK in relation to tax relief claims for R&D were declared invalid by HMRC since a new documentation requirement came into effect from 8 August.


This was the first real sign of the “bite” from some of the previously announced compliance changes to R&D tax relief claims; R&D tax reliefs for R&D spending from the beginning of April 2023 have reduced and many innovative SMEs preparing year-end accounts for financial periods which run beyond that date will now begin to feel the impacts from the reductions.


Firms most impacted by the new upper 25% rate in corporation tax are likely to be in the services sector, which accounts for nearly 80% of total UK economic output.


Businesses which invest in plant and machinery are less likely to be affected because of capital allowances, Stephen added.


HMRC publicly states that its aim is to pay 85% of SME payable tax credits within 40 days.


According to official figures, government support for R&D through the tax reliefs rises to more than £9 billion in 2027-28 from £6.7 billion in 2020-21.


The R&D tax credits system, set up to promote innovation and growth, goes back to 2000 when the EU established what is now known as the SME Scheme, aimed at small to medium size companies.

In the UK large companies lobbied heavily for a second scheme - this led to the formation of the large company scheme in 2002, the RDEC (Research and Development Expenditure Credit) scheme.


Accounting for the two schemes has remained completely different; in the SME scheme all adjustments are made on the corporation tax return while RDEC is calculated as a percentage of a company’s qualifying R&D expenditure and is taxable as trading income.


HMRC accounts for 2021 to 2022 estimate the level of error and fraud within corporation tax R&D reliefs to be £469 million or 4.9% of related expenditure; this comprises £430 million (7.3%) in the SME scheme and £39 million (1.1%) in the RDEC scheme.


There are government proposals to merge the two R&D tax relief schemes and potentially revamp permissible qualifying activity and claimant criteria.


Azets recently surveyed 42,000 client businesses as part of its response to the proposals. Nearly 13% of respondents thought the proposals for a single scheme to be positive, just over 51% considered it negative and nearly 36% were undecided as to its potential impact.


Tim Croft, Azets’ National Head of R&D Tax Relief, wrote to the government detailing the results of these two surveys and adding the firm’s own technical queries.


He said at the time: “Although most of our feedback has indicated that our clients are largely in favour of a single scheme, they are generally not convinced that the current proposals are the best way ahead.”


Most Read

Act Now On Looming Shake-Up Of Tenants’ Rights

Act Now On Looming Shake-Up Of Tenants’ Rights

A senior lawyer at a south coast legal firm has urged landlords and lettings agents to ‘get ahead of what is to come’ as the countdown begins to a major reform of the private rented sector.

Sustainability Chain Takes Centre Stage To Unlock Green Potential

Sustainability Chain Takes Centre Stage To Unlock Green Potential

Dozens of businesses keen to put clean growth and sustainability at the heart of their everyday operations are set to attend a free conference and exhibition in Basingstoke.

Andy Murray’s New Puppy Bonnie Lands Her First Official Role

Andy Murray’s New Puppy Bonnie Lands Her First Official Role

Andy Murray’s adorable puppy Bonnie has landed her first role at just 8-months-old, as the pair team up with Purina PRO PLAN® for an exciting new partnership.

Categories

  • Writer: Paul Andrews
    Paul Andrews
  • Sep 28, 2023
  • 3 min read

ree

UK accountancy firm Azets is seeing a rise in R&D claims but warns against companies trying to use the government-backed tax relief scheme as a ‘backdoor’ way to avoid paying more corporation tax.


Valid R&D claims have the additional benefit of reducing corporation tax liabilities on annual profits of £250,000-plus. Successful claims, which can often amount to tens of thousands of pounds, appear as a credit in the tax part of the profit/loss account and are exempt from corporation tax.


The original 19% corporation tax rate still applies to profits below £50,000, with marginal relief on profits up to the £250,000 threshold. Then the new 25% rate – a 6% rise – kicked in from 1 April this year.


Stephen Harris, a corporate tax expert with UK top 10 accountancy Azets, working from the Durham office, said: “With corporation tax rates having increased to 25% when profits are over £250,000, valid R&D claims have the additional benefit of reducing corporation tax liabilities. Whilst the rate of relief has reduced, the tax relief available is still substantial.”


He added: “Companies thinking of reducing the tax take on annual profits through R&D tax reliefs need to ensure they get professional advice to avoid falling foul of HMRC, which is rightly targeting fraudulent claims.”


Azets warned earlier this month [September] that nearly half of submissions made by agents across the UK in relation to tax relief claims for R&D were declared invalid by HMRC since a new documentation requirement came into effect from 8 August.


This was the first real sign of the “bite” from some of the previously announced compliance changes to R&D tax relief claims; R&D tax reliefs for R&D spending from the beginning of April 2023 have reduced and many innovative SMEs preparing year-end accounts for financial periods which run beyond that date will now begin to feel the impacts from the reductions.


Firms most impacted by the new upper 25% rate in corporation tax are likely to be in the services sector, which accounts for nearly 80% of total UK economic output.


Businesses which invest in plant and machinery are less likely to be affected because of capital allowances, Stephen added.


HMRC publicly states that its aim is to pay 85% of SME payable tax credits within 40 days.


According to official figures, government support for R&D through the tax reliefs rises to more than £9 billion in 2027-28 from £6.7 billion in 2020-21.


The R&D tax credits system, set up to promote innovation and growth, goes back to 2000 when the EU established what is now known as the SME Scheme, aimed at small to medium size companies.

In the UK large companies lobbied heavily for a second scheme - this led to the formation of the large company scheme in 2002, the RDEC (Research and Development Expenditure Credit) scheme.


Accounting for the two schemes has remained completely different; in the SME scheme all adjustments are made on the corporation tax return while RDEC is calculated as a percentage of a company’s qualifying R&D expenditure and is taxable as trading income.


HMRC accounts for 2021 to 2022 estimate the level of error and fraud within corporation tax R&D reliefs to be £469 million or 4.9% of related expenditure; this comprises £430 million (7.3%) in the SME scheme and £39 million (1.1%) in the RDEC scheme.


There are government proposals to merge the two R&D tax relief schemes and potentially revamp permissible qualifying activity and claimant criteria.


Azets recently surveyed 42,000 client businesses as part of its response to the proposals. Nearly 13% of respondents thought the proposals for a single scheme to be positive, just over 51% considered it negative and nearly 36% were undecided as to its potential impact.


Tim Croft, Azets’ National Head of R&D Tax Relief, wrote to the government detailing the results of these two surveys and adding the firm’s own technical queries.


He said at the time: “Although most of our feedback has indicated that our clients are largely in favour of a single scheme, they are generally not convinced that the current proposals are the best way ahead.”


Most Read

Act Now On Looming Shake-Up Of Tenants’ Rights

Act Now On Looming Shake-Up Of Tenants’ Rights

A senior lawyer at a south coast legal firm has urged landlords and lettings agents to ‘get ahead of what is to come’ as the countdown begins to a major reform of the private rented sector.

Sustainability Chain Takes Centre Stage To Unlock Green Potential

Sustainability Chain Takes Centre Stage To Unlock Green Potential

Dozens of businesses keen to put clean growth and sustainability at the heart of their everyday operations are set to attend a free conference and exhibition in Basingstoke.

Andy Murray’s New Puppy Bonnie Lands Her First Official Role

Andy Murray’s New Puppy Bonnie Lands Her First Official Role

Andy Murray’s adorable puppy Bonnie has landed her first role at just 8-months-old, as the pair team up with Purina PRO PLAN® for an exciting new partnership.

Categories

Vail Williams Secures New Premises For Patient Transport Group

Vail Williams Secures New Premises For Patient Transport Group

Property consultancy Vail Williams has secured seven properties in Berkshire, Buckinghamshire, Oxfordshire and Frimley in Surrey totalling 78,000 sq ft, for an expanding patient transport specialist.

Dina Foods Boosts Manufacturing Capacity

Dina Foods Boosts Manufacturing Capacity

Family run Mediterranean bakery, confectionery and savouries supplier Dina Foods has invested £1m over the last three years in an ongoing programme of manufacturing upgrades, as demand for its authentic foods grows.

Forest Start-Up Gets Top Marque

Forest Start-Up Gets Top Marque

A cutting-edge Hampshire start-up that provides dry wood for burning has marked its anniversary by achieving the New Forest Marque.

Recent Posts

bottom of page